On February 21, the FDA announced that the shortage of semaglutide injection products has been resolved. Semaglutide has appeared on the FDA’s Drug Shortage
Continue Reading End of Semaglutide Shortage Means Big Changes for Prescribers and Compounders
On January 5, 2023, the Federal Trade Commission (“FTC”) published a Notice of Proposed Rulemaking (“NPRM”) which would broadly prohibit companies from entering into or enforcing non-competition agreements or clauses
Continue Reading FTC Proposes Broad Rule Banning Non-Compete Covenants with Physicians and Other Healthcare WorkersThe CDC has issued and updated specific guidance on the COVID-19/Coronavirus pandemic for health care professionals on its website (accessible here: CDC Coronavirus – Health Care Professionals) and has
Continue Reading COVID-19/Coronavirus Patient Notice and Acknowledgement Forms
We invite you to read Part 1 and Part 2 in a series of posts by Fox partner Dori K. Stibolt, regarding the new trend in ADA Title III
Continue Reading The Next Frontier in ADA Access Litigation – Online
The long-anticipated implementation of ICD-10 coding finally began this past Thursday, October 1, 2015. As of that date, government and commercial payors ceased to accept claims under the old coding
Continue Reading The Switch to ICD-10
These days, more often than not, physicians and up on the short end of the stick when it comes to new health care legislation. However, last month a bill was
Continue Reading Pennsylvania Senate Bill would Limit Retroactive Denials
Physicians who reassign their right to bill the Medicare program can still be liable for false claims
Continue Reading OIG Alert Encourages Physicians To Use Care When Reassigning Medicare Payments
A recent USDOJ settlement highlights the need for physicians to pay close attention to their dealings with medical device companies.
Continue Reading Physicians Forewarned – The Impact of Medical Device Fraud on Physicians’ Practices
The emergence of narrow network HMO products is a trend worth watching for several reasons: first, it demonstrates that third party payers are aggressively seeking to better manage health care costs and are looking for innovative ways to do so; and, second, it is apparent that as new products are developed, those providers who are integrated (both horizontally and vertically) are most likely to be the players of choice.
Continue Reading “Narrow Network” HMOs — An Emerging Trend Worth Watching
HHS Proposed Regs Would Give Patients Direct Access to Lab Results
Continue Reading HHS Proposed Regs Would Give Patients Direct Access to Lab Results